Structural basis for Nirmatrelvir in vitro efficacy against SARS-CoV-2 variants
S. E. Greasley, S. Noell, O. Plotnikova, R. A. Ferre, W. Liu, B. Bolanos, K. F. Fennell, J. Nicki, T. Craig, Y. Zhu, A. E. Stewart, C. M. Steppan
This study evaluates nirmatrelvir's in vitro efficacy against SARS-CoV-2 variants, finding it maintains potency against Omicron and other variants.
bioRxiv · Jan 17, 2022Biochemistry